Recent genome-wide studies of cataloging somatic gene variations in cancer have identified mutations in intergenic sequences encoding regulatory elements and in KTM2C (MLL3) and MLL4 in both hematological malignancies and solid tumors. The gene discussed is KMT2C; the disease is hematologic disorder.